Sodium orthovanadate affects growth of some human epithelial cancer cells (A549, HTB44, DU145)

Andrzej Klein1, Przemyslaw Holko, Janusz Ligeza

  • 1Department of General Biochemistry, Faculty ofBiochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Kraków, Poland.

Folia Biologica
|December 6, 2008
PubMed

Insights

Sodium orthovanadate (Na3VO4) inhibits the growth of human lung, kidney, and prostate cancer cells in a dose-dependent manner. It also induces apoptosis in lung and prostate cancer cells, showing potential as an anti-cancer agent.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Cancer cell growth is a complex process involving autocrine signaling pathways.
  • Novel therapeutic agents are continuously being investigated to target cancer cell proliferation and induce apoptosis.
  • Orthovanadate compounds have shown promise in preclinical cancer research.

Purpose of the Study:

  • To investigate the effect of sodium orthovanadate (Na3VO4) on the autocrine growth of human carcinoma cell lines A549 (lung), HTB44 (kidney), and DU145 (prostate).
  • To evaluate the cytotoxic capabilities of Na3VO4, including its ability to induce tumor cell apoptosis.
  • To compare the effects of Na3VO4 with paclitaxel in specific cancer cell lines.

Main Methods:

  • Cell viability assays using N-hexa-methylpararosaniline (crystal violet) and bromide3-(4,5-dimethyltio-azo-2)-2,5-diphenyl-tetrazole (MTT).
  • Differential staining with HOECHST33258 and propidium iodide to assess apoptosis and necrosis.
  • Statistical analysis including MANOVA test for time-dependent effects.

Main Results:

  • Na3VO4 demonstrated time- and dose-dependent inhibition of A549, HTB44, and DU145 cell growth within the 1-20 microM range.
  • DU145 cells showed the highest sensitivity to Na3VO4, with approximately 98% growth inhibition at 20 microM.
  • Na3VO4 induced apoptosis in A549 and DU145 cells, with varying sensitivity compared to paclitaxel depending on cell type and incubation time.

Conclusions:

  • Sodium orthovanadate exhibits significant anti-proliferative and pro-apoptotic effects on human lung and prostate cancer cells.
  • Renal HTB44 cells showed relative insensitivity to Na3VO4 up to 15 microM concentrations.
  • Na3VO4 represents a potential therapeutic agent for certain cancers, warranting further investigation, particularly in comparison to established chemotherapeutics like paclitaxel.

Related Concept Videos